We are excited to reunite with the global pharmaceutical industry at CPHI Milan 2026, taking place at Fiera Milano, Italy, from 6–8 October 2026.
We look forward to welcoming you to #14A50, where we will showcase our quality-driven manufacturing capabilities, strong R&D expertise, and solutions for global markets.

We are proud to have been included in the Capital 500 survey once again. The survey, conducted by Capital, one of Turkey’s leading business and economy magazines, ranks the country’s 500 largest private companies.
READ MORE
As of April 2026, Polifarma has started the gradual transition to the QR code-based Electronic Package Leaflet (e-Leaflet) system.
WATCH NOW
With our global market experience and high-quality manufacturing approach spanning from APIs to finished products, Polifarma participated in CPHI South East Asia, held in Bangkok from July 8–10, 2026.
We would like to thank all visitors for the great interest shown in our booth.

With our integrated production capabilities spanning from APIs to finished products, strong R&D infrastructure, and advanced manufacturing technologies, we proudly took our place once again at CPHI China 2026, held at the Shanghai New International Expo Centre.
We would like to thank all our visitors for their interest and valuable time.


Polifarma’s journey, which began in 1986 with the belief of adding value to human life, has now reached its 40th year.
What started as a step taken with a strong sense of responsibility has evolved into a powerful story—transforming ideas into production and solutions that touch human lives.
Our 40th year represents our Ruby Year. Just like a ruby that forms patiently over time and gains value as it matures, it symbolizes Polifarma’s growing strength, resilience, and lasting impact over the years.
Today, Polifarma continues to create value for health with its strong R&D infrastructure and production capacity.



At this significant event, which also included October 29th — the 102nd anniversary of our Republic, we were proud to represent our country in the best way possible as the rising star of the Turkish pharmaceutical industry.
We will continue to produce, develop, and deliver innovative solutions for the health of the world and a stronger future.

From 25–27 November 2025, we will be participating in CPHI & PMEC India, one of the most significant global meeting points of the pharmaceutical industry. At this major event, where we will showcase our innovative solutions in Active Pharmaceutical Ingredients (API) and Finished Dosage Forms (FDF), we invite you to visit our stand and discover Polifarma’s strong innovations in the API field.
India Expo Centre, Greater Noida, Delhi NCR - Stand: 3G37

We have proudly climbed 57 places compared to last year in “Top 500 Companies by R&D Expenditures 2024” and now rank 76th among all industries! In the pharmaceutical sector, we are honored to be listed among the top 10 companies.
READ MORE
We would like to thank all our esteemed visitors who visited our booth at the WHX Cape Town Fair, held at the Cape Town International Convention Centre between 2–4 September 2025.
We will continue to work for the health of our country and the world, contributing to public health with our innovative treatment solutions!

We are proud to be ranked among Türkiye’s largest 500 private companies in the “Capital 500” survey conducted by Capital magazine.
With our motto “We Stand by Life,” we continue to work for human health and our country, moving steadily towards greater goals.
READ MORE
We are proud to announce that we ranked 199th in the Istanbul listing of the Fortune 500 Türkiye 2024, which ranks the largest companies in Türkiye based on their 2024 financial statements.
READ MORE
